Delays and Disruptions in Cancer Health Care Due to COVID-19 Pandemic: Systematic Review.

Riera R, Bagattini ÂM, Pacheco RL, Pachito DV, Roitberg F, Ilbawi A. · 2021

Read Delays and Disruptions in Cancer Health Care Due to COVID-19 Pandemic: Systematic Review. by Riera R, Bagattini ÂM, Pacheco RL, Pachito DV, Roitberg F, Ilbawi A. (2021) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc8081532.txt.

Introduction

Riera and co-authors review how the COVID-19 pandemic delayed and disrupted cancer care worldwide. People with cancer faced a double risk. The virus itself threatened them more than most. At the same time, strained health systems cut the services they depend on. The team ran a systematic search across major databases. Sixty-two studies met their inclusion rules.

None of the 62 studies reached high methodological quality. The review sorted the harm into 38 categories of delay and disruption. Shrinking service capacity drove most of them. Cancer surgeries fell, radiotherapy slipped, and clinic visits were delayed or cancelled. Facilities reported disruption rates up to 77.5% in the worst-hit reports. Supply chains and staff availability suffered almost as much. The authors urge standard ways to measure such harm.

Catalog record

CREATORRiera R, Bagattini ÂM, Pacheco RL, Pachito DV, Roitberg F, Ilbawi A.
YEAR2021
COLLECTIONPAPERS
FORMATTXT
FILE SIZE44 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC8081532

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Delays and Disruptions in Cancer Health Care Due to COVID-19 Pandemic: Systematic Review By Rachel Riera, Ângela Maria Bagattini, Rafael Leite Pacheco, Daniela Vianna Pachito, Felipe Roitberg, Andre Ilbawi Published in: JCO Global Oncology DOI: 10.1200/GO.20.00639 ABSTRACT Abstract PURPOSE There has been noteworthy concern about the impact of COVID-19 pandemic on health services including the management of cancer. In addition to being considered at higher risk for worse outcomes from COVID-19, people with cancer may also experience disruptions or delays in health services. This systematic review aimed to identify the delays and disruptions to cancer services globally. METHODS This is a systematic review with a comprehensive search including specific and general databases. We considered any observational longitudinal and cross-sectional study design. The selection, data extraction, and methodological assessment were performed by two independent reviewers. The methodological quality of the studies was assessed by specific tools. The delays and disruptions identified were categorized, and their frequency was presented. RESULTS Among the 62 studies identified, none exhibited high methodological quality. The most frequent determinants for disruptions were provider- or system-related, mainly because of the reduction in service availability. The studies identified 38 different categories of delays and disruptions with impact on treatment, diagnosis, or general health service. Delays or disruptions most investigated included reduction in routine activity of cancer services and number of cancer surgeries; delay in radiotherapy; and delay, reschedule, or cancellation of outpatient visits. Interruptions and disruptions largely affected facilities (up to 77.5%), supply chain (up to 79%), and personnel availability (up to 60%). CONCLUSION The remarkable frequency of delays and disruptions in health care mostly related to the reduction of the COVID-19 burden unintentionally posed a major risk on cancer care worldwide. Strategies can be proposed not only to mitigate the main delays and disruptions but also to standardize their measurement and reporting. As a high number of publications continuously are being published, it is critical to harmonize the upcoming reports and constantly update this review. INTRODUCTION There has been noteworthy concern about the impact of COVID-19 pandemic on essential health services including the management of cancer. In addition to being considered at higher risk for complications and worse outcomes from COVID-19,1 people with cancer may also experience disruptions or delays in services as a result of stressed health systems as well as increased susceptibility to the physical and psychological effects of social isolation and financial restrictions. Delays and disruptions because of the pandemic may directly or indirectly affect screening, diagnosis, treatment, palliative care, and rehabilitation of patients with cancer. Modeled and real-world data are increasingly demonstrating that an increase in cancer-related deaths will occur because of the effect of the pandemic on health systems, as recently seen in a study from the United Kingdom estimating a 20% increase in cancer-related deaths over the next 12 months.2 CONTEXTKey ObjectiveWhat are the types and frequency of the delays and disruptions in cancer health care because of COVID-19 pandemic?Knowledge GeneratedThirty-eight different categories of delays and disruptions with impact on treatment, diagnosis, or general health service were identified.Delays and disruptions most investigated included reduction in routine activity of cancer services and number of cancer surgeries; delay in radiotherapy; and delay, reschedule, or cancellation of outpatient visits. Interruptions and disruptions largely affected facilities (up to 77.5%), supply chain (up to 79%), and personnel availability (up to 60%).RelevanceThe frequency of delays and disruptions identified was remarkable, showing a relevant impact of the pandemic on the care of patients with cancer.Strategies can be proposed not only to mitigate the main delays and disruptions but also to standardize their measurement and reporting. Identifying and estimating the frequency and understanding the dynamics of these limitations are critical for planning strategies to mitigate the effects of the pandemic on cancer patient outcomes. Herein, we conducted a systematic review to identify, categorize, and estimate the frequency of delays and disruptions in cancer health care as a result of the COVID-19 pandemic considering different countries and types of cancer. METHODS Study Design and Setting This systematic review was conducted at the Centre of Health Technology Assessment, Hospital Sírio-Libanês, through a collaboration with the WHO. This study was conducted in accordance with the recommendations of Cochrane Handbook for Systematic Reviews of Interventions3 considering those sections relevant for a systematic review of frequency. The protocol was prospectively registered at the PROSPERO database (registration number CRD42020196708), and the reporting was written following the PRISMA statement.4 Criteria for Including Studies Taking into account the research question of interest, we considered the following study designs: observational longitudinal comparative studies (cohort or case-control), observational noncomparative studies (case series and case studies reporting the experience of a specific cancer service), cross-sectional studies (prevalence, survey, or analytical cross-sectional), controlled before-and-after studies, and uncontrolled before-and-after studies (including interrupted time series studies with two or more measures before and after the event of interest). Reports of a single individual case were not considered. We did not consider studies assessing the effects of any intervention, strategy, or recommendation adoption for mitigating the impact of COVID-19 on cancer care since these studies are being considered in a second review from our group. Adults or children with confirmed diagnosis or under investigation for cancer were considered as participants for this review. Any type of oncology service or hospital was considered for assessing the impact of strategies related to healthcare policies and health systems (public or private). We considered all types of delays and disruptions in services related to cancer treatment, including delays in timely presentation, diagnosis, and referrals throughout the patient pathway, that were classified as follows: (1) delays or disruptions in diagnosis (such as delays, interruptions, and/or changes in volumes of new patients with cancer), (2) delays or disruptions in treatment (such as delays in initiating care, interruptions, and/or changes in treatment plans including reduction in services provided), and (3) general disruptions in cancer services. Delays and disruptions reported by the primary studies should be experienced or measured by their author(s) from real-world data, instead of being estimated or obtained by a hypothetical scenario. Structural or process factors were identified and classified as follows: (1) provider- or system-related delays or disruptions such as medicine stockouts or shortages and other health product stockouts or shortages including devices, personal protective equipment, and laboratorial or image tests; (2) reduction of personnel such as workforce shortage or reduced work time; (3) any change in cancer treatment plan and reduction in service availability including overall reduction in any activity such as medical visits, surgeries, procedures, and radiotherapy and chemotherapy sessions; (4) measures adopted by providers aiming to reduce COVID-19 risk of infection that unintentionally translated into delays or disruptions in cancer care; (5) patient-related delays or disruptions such as delays related to financial shortfall, medical comorbidities, lack of family support, and/or fear of getting infected by SARS-CoV-2; and (6) context-related delays because of social measures imposed during the pandemic, such as quarantine, lockdown, and social distancing, and COVID-19 infection. Findings of included studies were organized as follows: (1) reported by providers, patients, centers, and/or other respondents and (2) observed and/or measured. Search Strategy and Selection Criteria A comprehensive search of the literature was carried out using electronic searches with no restriction regarding date, language, or status of

Read the complete text